Asia-Pacific Advanced Wound Care Market Segmentation, By Product Type (Dressing, Therapy Devices, Biologics, and Others), Wound Care (Primary Wound Care, and Secondary Wound Care), Wound Class (Class I, Class II, Class III, and Class IV), End User (Hospitals, Wound Care Centres, Ambulatory Centres, Home Healthcare, Clinics, and Others), Distribution Channel (Direct Tenders and Retail) - Industry Trends and Forecast to 2031.
Asia-Pacific Advanced Wound Care Market Analysis
Wound infection affects the patient’s quality of life and hence demand effective healing method. There are several kinds of wound healing methods, including dressings, biological products including allografts, synthetic grafts, and therapy devices, among others. The increasing incidence of diabetes and associated chronic wounds and the increasing number of patients undergoing surgical procedures provide the market with lucrative growth. Another factor boosting market growth is technological advancements in wound care.
Asia-Pacific Advanced Wound Care Market Size
Asia-Pacific advanced wound care market size was valued at USD 2.53 billion in 2023 and is projected to reach USD 4.41 billion by 2031, with a CAGR of 7.2% during the forecast period of 2024 to 2031.
Report Scope and Market Segmentation
|
Attributes
|
Advanced Wound Care Key Market Insights
|
|
Segmentation
|
By Product Type: Dressing, Therapy Devices, Biologics, and Others
By Wound Care: Primary Wound Care, and Secondary Wound Care
By Wound Class: Class I, Class II, Class III, and Class IV
By End User: Hospitals, Wound Care Centres, Ambulatory Centres, Home Healthcare, Clinics, and Others
By Distribution Channel: Direct Tenders and Retail
|
|
Countries Covered
|
Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines and Rest of the Asia-Pacific.
|
|
Key Market Players
|
Smith & Nephew, 3M, Medline Industries, Inc., Mölnlycke Health Care AB, ConvaTec Inc., Baxter, Cardinal health, L&R Group, HARTMANN USA, Inc. (A subsidiary of PAUL HARTMANN AG), MiMedx, Johnson & Johnson Services, Inc, Integra LifeSciences Corporation, Coloplast Group, B. Braun Melsungen AG, Medtronic, Hollister Incorporated, Zimmer Biomet, and Elkem Silicones (A Subsidiary of China National Bluestar (Group) Co, Ltd.), among others.
|
Asia-Pacific Advanced Wound Care Market Definition
Wounds are defined as the breakdown of any protective function of the skin with or without the loss of the underlying connective tissue. Wounds are formed due to several reasons, including cuts, chemical exposure, friction, shear force, and diseases, among others. There are several kinds of wounds depending upon the severity and nature, including class I, class II, class III, and class IV. Wounds can be treated as primary or secondary intention depending upon the close or open wounds, among others.
Advanced Wound Care Market Dynamics
This section deals with understanding the market drivers, opportunities, restraints, and challenges. All of this is discussed in detail as below:
Drivers
- Increasing Cases of Chronic Wounds
Rapidly growing incidence of diabetes and chronic wounds is a major factor contributing to the growth of this market. Chronic diseases are among the most predominant and expensive health situations worldwide. Chronic diseases include diabetes, cancer, stroke, heart disease, hypertension, arthritis, respiratory diseases, oral diseases, and obesity. These can lead to long-term disability and hospitalization, which may reduce the quality of life and, ultimately, death.
In some parts of New Zealand, the rising incidence of early occurrence of type 2 diabetes is seen in many people. This has a certain risk of early death coupled with complications, including problems related to cardiac health. Some of the reasons responsible for the occurrence of chronic wounds such as the growing aging population and the increasing prevalence of diseases like overweight, hypertension, and the late side effects of radiation therapy.
For instance,
- According to IDF Diabetes Atlas, it is estimated that more than 96,000 children and adolescents under the age of 15 are diagnosed with type 1 diabetes every year, and 132,600 when the age number exceeds 20 years.
Chronic diseases are rapidly increasing day by day in many countries, and the Asia-Pacific accounts for the most number of cases of chronic diseases. The average suffering rate due to chronic disease is 7 out of 10 people, and increasing prevalence of chronic wounds such as diabetic ulcers and foot ulcers. Hence they need to go for various surgeries. Thus, the rising incidence of diabetes and associated chronic wounds will have an impact on the advanced wound care market, which will propel the market in the futuristic period.
- New Product Launches
Conventional wound care products are replaced with advanced wound care products due to their increased efficacy and effectiveness in managing wounds by offering rapid healing. The companies, including B. Braun Melsungen AG, Coloplast Group, and Integra LifeSciences, among others, are taking initiatives to launch new products with advanced technologies.
For instance,
- In May 2020, Integra LifeSciences announced a positive clinical result for Integra Bilayer Wound Matrix (IBWM). This product is part of the company’s regenerative technology portfolio, which uses collagen and amniotic products.
To attract more customers and to create new marketing opportunities for growing companies engaged in advanced wound care, healthcare professionals and researchers are developing new and innovative products, and this leads to the growth of the advanced wound care market.
- Increasing Number of Patients Undergoing Surgical Procedures
According to National Center for Biotechnology Information, wound infection is an important issue observed in surgical sections. The cause of infection is associated with the patient and their disease. Also, the wound infection depends on age, gender, contamination of the wound, time and type of operation and anesthesia, hospitalization duration, and wound drainage.
As per National Center for Biotechnology Information, approximately 6.5 million patients are affected by chronic wounds. It is estimated that more than USD 25 billion is spent per year on the treatment of chronic wounds. This is tremendously increasing due to the rising aging population, healthcare expenses, and diabetic and obese population in the Asia-Pacific region.
About 72% of patients with pressure ulcers at the age of 65 years underwent surgery. Among those hospitalized patients, about 9 out of 10 were covered by government health programs, in which around 66% and 23% were covered by Medicare state and Medicaid programs, respectively. Patients diagnosed with pressure ulcers are generally admitted to the hospital for medical reasons rather than pressure ulcers. The pressure ulcer patients are diagnosed with pneumonia, urinary tract infections (UTI), septicemia, respiratory failure, congestive heart failure (CHF), and critical diabetes mellitus (DM). The number of hospital patients who develop pressure ulcers has increased by approximately 63% in the last decade.
Opportunities
- Growth Potential in Emerging Economies
For the wound care practitioner, the most advanced dressings in developing countries are important. These materials are made of a wide range of products such as polyurethane, alginic acid salts, and other polysaccharides that are gelable; these products are used in wound care in developed countries. The circumstances are different in developing economies where traditional agents such as chlorhexidine, sodium hypochlorite, cetrimide, hydrogen-peroxide, and others are commonly available to wound care providers. Wound healing is an important process, and as the wound moves towards healing, the quality specification of a dressing increases.
For instance,
- According to World Health Organization, approximately 400 million people worldwide are dealing with diabetes. In developing countries, the age of diabetes is 45–64. By 2030, developing countries are predicted to have more people with diabetes, about 82 million of which are 65 years of age, than developed countries (48 million). The diabetic population has at a major risk of foot ulcers. Thus, this will directly affect on advanced wound care.
China's increasing technological advancement involves the treatment of wound care for better products and dressings to widen the market. The aging population of China is becoming increasingly prone to chronic, unhealing wounds due to complications such as cardiovascular diseases, obesity, and diabetes. In rural areas with poor access to health care, traditional treatments such as sutures, specialized wound dressings, and tools for wound debriding tend to gain acceptance. Many patients from all over the world are heading to countries in Asia-Pacific to get medical treatment as they need to save the expenditures on treatments. India and Thailand are the top destinations for medical tourism. Cost is often a highly concerning reason that patients are traveling for medical treatment.
- According to an article published in IJITEE, India is one of the major countries in medical tourism compared to other countries. Patients are enthusiastically approaching India because of prices, weather, community, and holidays. , The arrival of foreign tourists in India for medical treatment in the year 2015 is more than 7101.9. The annual growth rate is around 30%, and the profits earned at the end of 2015 were around USD 1482 million. Because of economic health services, 150,000 customers travel to India each year.
In various developing economies, treatable wounds and medical tourism are the major reasons for the development of advanced wound care. Most of the advanced dressings need to be available in the market in developing countries for wound care. New technologies and products for wound care are introduced in developing countries. Thus, this will help to maximize the growth of the advanced wound care market in developing countries.
Restraints/Challenges
However, the barriers to advanced wound care techniques and the high cost of the treatment process in some regions may impede the growth of advanced wound care, which is hampering the growth of the market. Additionally, high competition in medical technology industries and long lead time for the overseas qualification can be challenging factors for the growth of the market
This advanced wound care market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the lung cancer surgery market, contact Data Bridge Market Research for an Analyst Brief. Our team will help you to make an informed market decision to achieve market growth.
Asia-Pacific Advanced Wound Care Market Scope
Asia-Pacific advanced wound care market is segmented into product type, wound type, wound class, end user, and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.
Product Type
- Dressing
- Biologics
- Therapy Devices
- Others
Wound Class
- Class I
- Class II
- Class III
- Class IV
Wound Care
- Primary Wound Care
- Secondary Wound Care
End User
- Hospitals
- Wound Care Centers
- Ambulatory Centers
- Home Healthcare
- Clinics
- Others
Distribution Channel
- Direct Tender
- Retail
Advanced Wound Care Market Regional Analysis
The advanced wound care market is analysed, and market size insights and trends are provided by country, product type, wound type, wound class, end user, and distribution channels, as referenced above.
Countries covered in Asia-Pacific advanced wound care market are Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines and Rest of the Asia-Pacific.
Japan dominates the Asia-Pacific advanced wound care market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the rising need for the verification and validation of wound care treatment processes in the region, and rapid research development is boosting the market
The country section of the report also provides individual market-impacting factors and changes in regulations in the market that impact the current and future trends of the market. Data points, such as new and replacement sales, country demographics, disease epidemiology, and import-export tariffs, are some of the major pointers used to forecast the market scenario for individual countries. In addition, the presence and availability of global brands and their challenges faced due to high competition from local and domestic brands and the impact of sales channels are considered while providing forecast analysis of the country data.
Advanced Wound Care Market Share
The advanced wound care market competitive landscape provides details by the competitors. Details include company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies focus on the advanced wound care market.
Advanced Wound Care Market Leaders Operating in the Market Are:
- Smith & Nephew
- 3M
- Medline Industries, Inc.
- Mölnlycke Health Care AB
- ConvaTec Inc
- Baxter
- Cardinal health
- L&R Group
- HARTMANN USA, Inc. (A subsidiary of PAUL HARTMANN AG)
- MiMedx
- Johnson & Johnson Services, Inc.
- Integra LifeSciences Corporation
- Coloplast Group
- B. Braun Melsungen AG
- Medtronic, Hollister Incorporated
- Zimmer Biomet
- Elkem Silicones (A Subsidiary of China National Bluestar (Group) Co, Ltd.)
Latest Developments in Advanced Wound Care
- In August 2020, Medline Industries, Inc. expanded its business via expansion of its service in the Northeast region. The company has opened up a new product distribution facility in Uxbridge, Massachusetts. This initiative enhanced the company’s product distribution network and allowed it to generate more revenue in the advanced wound care market.
- In February 2020, Baxter acquired Seprafilm Adhesion Barrier from Sanofi. The product acquired is used as an adjunct in order to reduce the severity of adhesion in the case of abdominal and certain pelvic surgeries. This acquisition helped the company to penetrate its root in the advanced wound care market.
SKU-